Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Mesothelioma, Malignant 3 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solitary Fibrous Tumor, Pleural 1 Solid Neoplasms 1 Sarcoma 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Metastatic Solid Tumors 1 Metastatic NUT Carcinoma 1 Melanoma 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Cervical Adenocarcinoma 1 Carcinoma, Small Cell 1 Carcinoma, Neuroendocrine 1 Breast Neoplasms 1 Bone Neoplasms 1 Advanced NUT Carcinoma 1

Interventions

pembrolizumab 1 Platinum 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Solid Neoplasms × Platinum × Clear all

NCT04420884 2026-04-08

iintune-1

Takeda

Phase 1/2 Completed

Solid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡